ribavirin
Showing 1 - 25 of 363
HEAD & NECK Cancer Trial in New York (ribavirin)
Active, not recruiting
- HEAD & NECK Cancer
- ribavirin
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 11, 2023
Human Papillomavirus (HPV)-Related Malignancies, Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
Completed
- Human Papillomavirus (HPV)-Related Malignancies
- Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
- Ribavirin
-
Basking Ridge, New Jersey
- +5 more
Dec 14, 2022
Viral Hemorrhagic Fever Trial in Landstuhl (Ribavirin)
Recruiting
- Viral Hemorrhagic Fever
- Ribavirin
-
Landstuhl, APO Ae, GermanyLandstuhl Regional Medical Center
Apr 3, 2022
SARS-CoV Infection, Covid19 Trial in New Brunswick (Nitazoxanide, Placebo Nitazoxanide, Ribavirin)
Terminated
- SARS-CoV Infection
- Covid19
- Nitazoxanide
- +5 more
-
New Brunswick, New JerseyRobert Wood Johnson Medical School
May 3, 2022
HIV Trial in New Orleans (Ribavirin)
Completed
- HIV Infections
- Ribavirin
-
New Orleans, Louisiana
- +1 more
Oct 27, 2021
Hepatitis C Virus Trial in Aurora (ribavirin)
Completed
- Hepatitis C Virus
- ribavirin
-
Aurora, ColoradoUniversity of Colorado Denver
Aug 20, 2021
Follicular Lymphoma, Mantle Cell Lymphoma Trial in New York (Ribavirin)
Terminated
- Follicular Lymphoma
- Mantle Cell Lymphoma
- Ribavirin
-
New York, New YorkWeill Cornell Medicine
Sep 20, 2021
HIV Trial in United States (Ribavirin)
Completed
- HIV Infections
- Ribavirin
-
San Diego, California
- +4 more
Oct 28, 2021
HIV, Hepatitis B, Hepatitis C Trial (Adefovir dipivoxil, Peginterferon-alfa-2A, Ribavirin)
Withdrawn
- HIV Infections
- +2 more
- Adefovir dipivoxil
- +3 more
- (no location specified)
Oct 28, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +4 more
- (no location specified)
Jul 29, 2021
HIV Trial in Puerto Rico, United States (Ribavirin, Didanosine)
Completed
- HIV Infections
- Ribavirin
- Didanosine
-
Washington, District of Columbia
- +14 more
Oct 27, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +4 more
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +2 more
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +2 more
- (no location specified)
Jul 8, 2021
Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)
Not yet recruiting
- Liver Cancer
- Bevacizumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Feb 9, 2023
HIV, Hepatitis C Trial in United States (Ribavirin, Aldesleukin, Peginterferon alfa-2b)
Completed
- HIV Infections
- Hepatitis C
- Ribavirin
- +2 more
-
Los Angeles, California
- +7 more
Oct 28, 2021
Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-450/r/ABT-267, ABT-333,
Completed
- Hepatitis C Virus Infection
- +3 more
- ABT-450/r/ABT-267
- +2 more
- (no location specified)
Jul 8, 2021
Hemorrhagic Fever With Renal Syndrome Trial in Seoul (Ribavirin)
Enrolling by invitation
- Hemorrhagic Fever With Renal Syndrome
- Ribavirin
-
Seoul, Korea, Republic ofBrian Allgood Army Community Hospital (121st Combat Support)
Feb 10, 2021
Hepatitis C Infection Trial (Grazoprevir + Elbasvir, Ribavirin)
Completed
- Hepatitis C Infection
- Grazoprevir + Elbasvir
- Ribavirin
- (no location specified)
Jan 15, 2021
Chronic Hepatitis C Genotype 1 Trial (Boceprevir, Placebo, peginterferon alfa-2b)
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- Ribavirin
- (no location specified)
Jul 8, 2021